Whole genome expression analysis within the angiotensin

II-apolipoprotein E deficient mouse model of abdominal aortic

aneurysm by Rush, Catherine et al.
BioMed CentralBMC Genomics
ssOpen AcceResearch article
Whole genome expression analysis within the angiotensin 
II-apolipoprotein E deficient mouse model of abdominal aortic 
aneurysm
Catherine Rush, Moses Nyara, Joseph V Moxon, Alexandra Trollope, 
Bradford Cullen and Jonathan Golledge*
Address: The Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Australia
Email: Catherine Rush - catherine.rush@jcu.edu.au; Moses Nyara - moses.nyara@jcu.edu.au; Joseph V Moxon - joseph.moxon@jcu.edu.au; 
Alexandra Trollope - alexandra.trollope@jcu.edu.au; Bradford Cullen - bradford.cullen@gmail.com; 
Jonathan Golledge* - jonathan.golledge@jcu.edu.au
* Corresponding author    
Abstract
Background: An animal model commonly used to investigate pathways and potential therapeutic
interventions relevant to abdominal aortic aneurysm (AAA) involves subcutaneous infusion of
angiotensin II within the apolipoprotein E deficient mouse. The aim of this study was to investigate
genes differentially expressed in aneurysms forming within this mouse model in order to assess the
relevance of this model to human AAA.
Results: Using microarrays we identified genes relevant to aneurysm formation within
apolipoprotein E deficient mice. Firstly we investigated genes differentially expressed in the
aneurysm prone segment of the suprarenal aorta in these mice. Secondly we investigated genes that
were differentially expressed in the aortas of mice developing aneurysms relative to those that did
not develop aneurysms in response to angiotensin II infusion. Our findings suggest that a host of
inflammation and extracellular matrix remodelling pathways are upregulated within the aorta in
mice developing aneurysms. Kyoto Encyclopedia of Genes and Genome categories enriched in the
aortas of mice with aneurysms included cytokine-cytokine receptor interaction, leukocyte
transendothelial migration, natural killer cell mediated cytotoxicity and hematopoietic cell lineage.
Genes associated with extracellular matrix remodelling, such as a range of matrix
metalloproteinases were also differentially expressed in relation to aneurysm formation.
Conclusion: This study is the first report describing whole genome expression arrays in the
apolipoprotein E deficient mice in relation to aneurysm formation. The findings suggest that the
pathways believed to be critical in human AAA are also relevant to aneurysm formation in this
mouse model. The findings therefore support the value of this model to investigate interventions
and mechanisms of human AAA.
Background
Abdominal aortic aneurysm (AAA) affects approximately
5% of men and 1% of women aged >60 years [1]. The
principal concern with the condition is aortic rupture
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option for AAA is surgery and approximately 25,000 aor-
tic repairs are performed annually in the USA [2]. AAA
accounts for approximately 15,000 deaths annually in the
USA despite the increasing numbers of elective aortic
repairs [2,3]. There is increasing interest in using animal
models of AAA to investigate mechanisms important in
aneurysm development and progression in order to
develop new non-interventional treatments and better
ways of monitoring disease progression [4]. Currently
rodent models of AAA are most commonly employed,
particularly through infusion of angiotensin II in hyperli-
pidaemic mice, such as apolipoprotein E deficient (ApoE-
/-) animals [5-7]. This mouse model has a number of sim-
ilarities to human AAA such as the preponderance of
aneurysm formation in males and the focal nature of aor-
tic dilatation [5,6]. The model also displays a number of
differences from human AAA, for example aneurysms
commonly involve the suprarenal aorta, dissection is an
important histological finding and the infrarenal aorta is
rarely if ever affected [7]. In contrast the infrarenal aorta is
the most common site of AAA in humans. These and other
disparities between this mouse model and human AAA
stimulated us to investigate the gene expression profile of
aneurysms in the ApoE-/- mouse model. The aim of the
current study was to identify genes and pathways associ-
ated with aneurysm formation in the angiotensin II
infused ApoE-/- mouse model. We used three approaches.
Firstly we aimed to identify genes which might underlie
the protection of the infrarenal aorta from aneurysm for-
mation in ApoE-/- mice. Secondly we aimed to identify
genes which were differentially expressed within the aor-
tas of mice developing aneurysms in comparison to those
that did not. Finally we selectively examined whether the
differences in gene expression associated with aneurysm
formation translated into similar changes in protein
expression. The design of these studies is illustrated in
Table 1. Our findings suggest the importance of chemok-
ines, pro-inflammatory cytokines, leukocyte transend-
othelial migration mechanisms, a number of different
signalling pathways (such as the Janus kinase pathway)
and proteolytic mechanisms in aneurysm formation in
these mice supporting the relevance of this model to
human AAA [8-10].
Results
Comparison of gene expression in aneurysm prone 
suprarenal compared to aneurysm resistant infrarenal 
aorta
A total of 26,522 transcripts (73% of the reference list)
were expressed above background and compared between
segments. A total of 304 transcripts were differentially
expressed (1.5 fold, p < 0.05) between supra and infrare-
nal aortic segments (53 upregulated within the suprarenal
aorta and 251 upregulated within the infrarenal aorta). A
full list of transcripts is given in Additional File 1 and
examples of potentially relevant genes shown in Table 2.
A number of these genes may be relevant to the predilec-
tion of the suprarenal aorta to aneurysm formation based
on knowledge of their functional importance or their pre-
vious identification in human AAA association studies [9].
Ucn3 for example, which was downregulated in the supra-
renal aorta, has been demonstrated to antagonize angi-
otensin induced production of oxygen derived free
radicals in vitro and play a vascular protective role in ani-
mal models [11,12]. Pik3ap1, Dapk1 and Cd59 have pre-
viously been identified to be upregulated within human
AAA biopsies [9]. Since vascular smooth muscle apoptosis
and inflammation have been demonstrated to be impor-
tant mechanisms in human AAA, upregulation of Dapk1
and Cd59 may be relevant to the predilection of the supra-
renal aorta to aneurysm formation in ApoE-/- mice [8].
Perhaps more important to the predilection of the supra-
renal aorta to aneurysm formation are the downregula-
tion of a number of genes coding for structural
extracellular matrix proteins including Lama3, Myo18b
and the cytoskeletal protein Tuba8 (Table 2). Lama3 has
been identified to be downregulated within human AAA
biopsies [9].
Genes expressed in aortas from mice with aneurysms 
compared to those without aneurysms and controls
Maximum aortic diameters measured in the aortic arch,
thoracic, suprarenal and infrarenal aortas in saline con-
trols and mice exposed to angiotensin II that did and did
not develop aneurysms are shown in Table 3 for animals
used in the microarray experiment (study 2). Aortic diam-
eters were similar between non-aneurysmal angiotensin II
perfused mice and saline controls. We used Volcano Plots
to identify differentially expressed genes between groups
using our pre-defined criteria, i.e. 2-fold differential
expression and uncorrected p value < 0.05 by unpaired t-
test. The numbers of transcripts differentially expressed in
comparison between the 3 groups of mice are shown in
Additional File 2. 531 transcripts were differentially
expressed (two fold change, p < 0.05) between aortas of
mice exposed to angiotensin II which developed aneu-
rysms and those that did not develop aneurysms (aneu-
rysm resistant) (446 up and 85 downregulated, a full list
is given in Additional File 3). 1196 transcripts were differ-
entially expressed (two fold change, p < 0.05) between
aortas of mice exposed to angiotensin II which developed
aneurysms and saline controls (749 up and 447 downreg-
ulated, Additional File 4). 654 transcripts were differen-
tially expressed (two fold change, p < 0.05) between
aortas of mice exposed to angiotensin II which did not
develop aneurysms and saline controls (128 up and 526
downregulated, Additional File 5). To further analyse
these results, we concentrated on the transcripts differen-
tially expressed between the aortas of mice that had beenPage 2 of 20
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AAAs (n = 531 listed in Additional File 3). We considered
that genes identified by this analysis would be most likely
to represent those relevant to aneurysm formation or
resistance rather than simply reflecting the effects of angi-
otensin II. We also wanted to incorporate some of the
findings relevant to the saline control group as they ena-
bled us to have a measure of the baseline level of expres-
sion of different genes. This group allowed us to better
postulate genes upregulated in the AAA resistant aortas,
and thus of potential protective value against AAA. We
carried out hierachical clustering analysis incorporating
expression levels from all three groups of mice for the 531
transcripts that were differentially expressed in angi-
otensin II treated mice with and without aneurysms. This
analysis is illustrated in terms of a heatmap, with a gene
tree showing clustering of individual transcripts, in Figure
1. Each line in the heatmap represents a transcript with
mean upregulated (red) or downregulated (green) in
expression within the three groups. No change in expres-
sion is indicated in black. Hierachical clustering analysis
indicated four main patterns of transcript expression (Fig-
ure 1, patterns 1–4). Transcripts grouped in pattern 1 (104
transcripts) showed decreased expression in aneurysm
resistant aortas relative to other groups and included
genes such as Ccl5, and Mmp9 which have been noted to
be upregulated in human AAA biopsies (Additional File
6) [9]. Pattern 2 transcripts (325 transcripts) showed
increased expression in aneurysms and included many
genes associated with inflammation including matrix
metalloproteinase encoding genes (e.g. Mmp2), genes
encoding markers of inflammatory cells (Cd14, Cd68)
and many cytokine and chemokine genes (e.g. Il1b, Il6,
Ccl4, Ccl7, Ccl8, Ccl19, MMP2) (Table 4 shows a selected
list and Additional File 7 a full list). Many of these genes,
particularly those related to leukocyte chemotaxis, have
previously been identified as upregulated within human
AAA biopsies (highlighted in Table 4) [9,10]. Pattern 3
transcripts (17 transcripts) were downregulated in the aor-
tas of mice resistant to aneurysm formation. The differ-
ence between pattern 1 and pattern 3 transcripts is that in
pattern 1, genes are most highly expressed in the AAA
group, whereas pattern 3 genes are, in general, more
highly expressed in the saline group. This can be clearly
seen on the heatmap (Figure 1) where pattern 1 genes in
the AAA group are mainly coloured red compared to red/
black in saline group, whereas pattern 3 genes are red/
black in the AAA group and red in the saline group.
Although the clustering algorithim has separated these
groups of genes, we believe that both pattern 1 and pat-
tern 3 genes can be considered "pathogenic". Additional
File 8 shows transcripts (out of those in pattern 3) that
were associated with known genes and were significantly
downregulated (2-fold, p < 0.05) with respect to both
saline controls and mice that develop aneurysms. Two of
these "pathogenic" pattern 3 genes, namely Apoc1 (Apoli-
poprotein C-I) and Stxbp2 (syntaxin binding protein 2),
have been previously demonstrated to be upregulated
within biopsies of human AAA [9]. Pattern 4 transcripts
(85 transcripts) were upregulated in mice resistant to
aneurysm formation (examples shown in Table 5 and a
full list in Additional File 9) and we considered that
upregulation of these may be "protective" for aneurysm
formation. It is interesting to note that a number of the
genes identified in pattern 4 have been previously shown
to be downregulated within human AAA biopsies sup-
porting their potential protective role (see Table 5 for
examples) [9].
Based on previous studies demonstrating the importance
of inflammation in AAA we selected a number of inflam-
mation associated markers to validate which were differ-
entially expressed between aortic aneurysms and control
aortas [9]. Initially we confirmed the up-regulation of Il6,
Table 1: Summary of the included studies.
Study Comparison Design Method Mice Genes identified
1 Paired supra and infrarenal aortas Pooled samples Codelink mouse whole 
genome bioarray (36227 
genes)
10 Differentially expressed between 
AAA prone supra and infrarenal aorta
2 Whole aortas of mice exposed to 
angiotensin II that did and did not 
develop aneurysms and saline infused 
controls
Individual mice Illumina mouse sentrix 6 
microarray (46,628 genes).
18 Differentially expressed between the 
3 groups revealing aneurysm-
associated and "protective" genes
3 Suprarenal aortas of mice exposed to 
angiotensin II that did and did not 
develop aneurysms
Individual mice ELISA and IHC 18* Validate findings from the microarray 
in study 2 for Tnfrsf11b, Tgfb1, and 
inflammatory cell markers.
* 10 further mice died and were excluded from this study.Page 3 of 20
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time PCR (Table 6). These genes were highly upregulated
in aortic aneurysms by comparison to aortas from both
control groups in microarray studies and real time PCR
(see Tables 4 and 6). We also confirmed the differential
expression of the Tnfrsf11b (osteoprotegerin) and Tgfb1
(TGF-b1) genes across the three groups translated to dif-
ferences in protein expression using samples from study 3.
We measured the concentration of OPG and TGFb-1 in
the suprarenal segments of angiotensin II treated mice
that developed AAA (mean maximum diameter 2.67 ±
0.24, n = 9) and those that did not (mean maximum
diameter 1.26 ± 0.25, n = 9, p < 0.01) and found that both
proteins were expressed at higher concentrations in aortas
Table 2: Examples of genes differentially expressed between paired supra and infrarenal aortas.
Symbol Gene ID Gene Name Mean expression ratio* P value
Adprhl1 234072 ADP-ribosylhydrolase like 1 3.11 0.015
Lgtn 16865 Ligatin 2.91 0.041
Fabp3 14077 Fatty acid binding protein 3 1.86 0.043
Pik3ap1† 83490 phosphoinositide-3-kinase adaptor protein 1 1.85 0.030
Dapk1† 69635 Death associated protein kinase 1 (Dapk1) 1.73 0.028
Tuba8 53857 tubulin, alpha 8 1.68 0.045
Cd59a† 12509 CD59a antigen 1.68 0.007
Cxcl13 55985 chemokine (C-X-C motif) ligand 13 1.56 0.021
Tgfbr3† 21814 Transforming growth factor, beta receptor III 1.53 0.030
Myo18b 74376 myosin XVIIIb 0.59 0.006
Ucn3 83428 urocortin 3 0.57 0.022
Srd5a2 94224 steroid 5 alpha-reductase 2 0.56 0.029
Dsc3 13507 desmocollin 3 0.52 0.037
Lama3† 16774 laminin, alpha 3 0.52 0.025
Trat1† 77647 T cell receptor associated transmembrane adaptor 1 0.51 0.008
Shbg 20415 sex hormone binding globulin 0.42 0.034
Akr1b7 11997 aldo-keto reductase family 1, member B7 0.24 < 0.001
Shown are a subset of the 304 gene transcripts that were differentially expressed in suprarenal compared to infrarenal aortic segments (1.5-fold, 
uncorrected p value < 0.05 calculated with paired t-test; for a full list see Additional File 1). The genes were selected from the full list based on the 
potential relevance to AAA. Genes highlighted with † have previously been identified as associated with human AAA in a whole genome expression 
study [9]. *Ratio of relative gene expression in supra compared to infrarenal aortic segments from 10 paired samples (5 pairs of arrays due to 
pooling of 2 aortic segments for each analysis).Page 4 of 20
(page number not for citation purposes)
BMC Genomics 2009, 10:298 http://www.biomedcentral.com/1471-2164/10/298of mice with aneurysms, p < 0.05 (Figure 2A). Using
immunohistochemistry we demonstrated that OPG was
found within the medial layers and remodeled adventitia
of aortas with aneurysm, whereas little was detected in
aneurysm-resistant aortas or saline controls (Figure 2B).
Investigation of known functional KEGG pathways related 
to the differentially expressed genes
KEGG pathway analysis of transcripts upregulated in the
AAA group compared to the no AAA group using Webge-
stalt, revealed that of the 302 known genes in the input
list, 116 of these could be assigned to one or more KEGG
pathways (Additional File 10). This pathway analysis
revealed a significant enrichment for genes involved in
leukocyte recruitment, transendothelial migration and B
lymphocyte receptor signalling and identified a number
of cell lineage specific genes associated with aneurysm
(Table 7). Chemokine genes upregulated in aneurysms
included Ccl21 and Ccl19 (which attract T cells and den-
dritic cells), Ccl7 (attracts monocytes), Cxcl9 (attracts T
cells), Cxcl12 (attracts lymphocytes) and Cxcl5 (attracts
neutrophils), suggesting that all these inflammatory cell
types are recruited to mouse aortic aneurysms. Genes that
can be considered as markers for the following cell types
were upregulated in aneurysms (Additional Files 5 and 6):
neutrophils (Csf3r); T lymphocytes (Cd3d) and B lym-
phocytes (Blnk, Cd72, various immunoglobulin genes);
and monocyte/macrophages (Cd14, Cd68). We used IHC
to confirm the recruitment of neutrophils, T and B lym-
phocytes, dendritic cells and monocyte/macrophages to
aneurysmal but not aneurysm-resistant aortas (Figure 3).
Discussion
Mouse models of human diseases are potentially impor-
tant tools with which to investigate mechanisms involved
in the pathology and identify new treatments. Currently a
number of animal models of human AAA are available
[4]. Many of these models require significant interven-
tions such as exposing the aorta and subsequently infus-
ing or painting elastolytic solution on a segment of the
artery to induce weakening and inflammation. Currently
the angiotensin II infusion model is most commonly
used, possibly due to the relatively ease with which aneu-
rysms are produced and the lack of requirement for what
might be considered artificial manipulation of the aorta.
To our knowledge this is the first study to examine whole
genome expression in relation to aneurysm formation
within this model. Our findings demonstrate that aneu-
rysms forming in ApoE-/- mice have marked influx by a
range of inflammatory cells and upregulation of cytokines
which have all been previously demonstrated in human
AAA [8,9,13-17]. These findings confirm those from more
selective previous studies within this model [5-7,18-22].
Importantly they suggest the value of this model for inves-
tigating the inflammatory and cytokine aspects of human
AAA. We also demonstrated the upregulation of a range of
chemokines, cytokines and proteolytic enzymes, such as
Ccl4, Ccl8, Il6 and Mmp2 which have been previously
implicated in human AAA [9,10,23,24]. The upregulation
of the latter genes in AAAs was validated using real time
PCR. We identified genes up or downregulated in the aor-
tas of mice resistant to aneurysm formation suggesting
potentially protective and pathological roles of these
genes respectively in AAA. Sclerostin expression is
decreased within human AAA biopsies compared to con-
trols, however the significance of this finding is unclear
[9]. We found increased expression of the sclerostin gene
(Sost) in the aortas of mice resistant to aneurysm forma-
tion compared to both mice with aneurysms and saline
controls, suggesting that sclerostin may play a role in
inhibiting aortic dilatation. The ability of sclerostin to
antagonise transforming growth factor beta, which has
been linked to aortic aneurysm development, could be of
significance in an aortic protection role for this gene [25].
Acta2 (vascular smooth muscle actin) expression was
increased in aortas resistant to aneurysm formation com-
pared to other groups. Acta2 encodes the single most
abundant protein in vascular smooth muscle cells, and
mutations in the human gene are associated with ascend-
ing thoracic aortic aneurysms and dissections [26].
Table 3: Maximum aortic diameters of mice exposed to saline or angiotensin II that did or did not develop macroscopic aneurysms 
used in the microarray experiment (study 2).
Group Diameter (mm)
Arch Thoracic Suprarenal Infrarenal Average Maximum#
Angiotensin II and aortic aneurysm (n = 5) 1.61 ± 0.18 1.11 ± 0.15 2.06 ± 0.48 0.72 ± 0.18 1.38 ± 0.17
Angiotensin II and no aortic aneurysm (n = 7) 1.34 ± 0.10 0.9 ± 0.10 1.13 ± 0.19 0.65 ± 0.09 1.0 ± 0.07
Saline controls (n = 6) 1.35 ± 0.11 1.16 ± 0.11 0.97 ± 0.08 0.67 ± 0.06 1.0 ± 0.06
Data represent mean values ± standard deviation; #calculated by averaging maximum diameters for all 4 aorta regions in each mouse.Page 5 of 20
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Gene symbol Gene ID Description; synonym Fold increase cf no 
AAA
P value Fold increase cf saline P value
Chemokines/receptors
Cxcl10 15945 chemokine (C-X-C motif) 
ligand 10; IP-10
2.766 0.0284 2.487 0.0374
Cxcl12 20315 chemokine (C-X-C motif) 
ligand 12; SDF-1
3.022 0.0121 3.03 0.00358
Cxcl14 57266 chemokine (C-X-C motif) 
ligand 14; MIP-2g
3.812 0.0092 2.801 0.0373
Ccl2† 20296 chemokine (C-C motif) 
ligand 2; MCP-1
2.263 0.021 3.325 0.00493
Ccl4† 20303 chemokine (C-C motif) 
ligand 4; MIP-1B
4.232 0.0154 7.864 0.00302
Ccl7 20306 chemokine (C-C motif) 
ligand 7; MCP-3
3.183 0.00247 5.009 0.000346
Ccl8† 20307 chemokine (C-C motif) 
ligand 8; MCP-2
3.12 0.00645 3.911 0.000657
Ccl19 24047 chemokine (C-C motif) 
ligand 19; ELC
2.119 0.00758 2.629 0.00228
Ccl21a 65956 chemokine (C-C motif) 
ligand 21; SLC
3.577 0.000615 2.66 0.0052
Cx3cr1 13051 Cx3cr1 2.602 0.00131 3.99 0.000356
Ccr5† 12774 CD195 2.224 0.00187 3.358 0.000184
MMPs
Mmp2† 17390 matrix metalloproteinase 2 2.513 0.000969 3.123 0.000609
Mmp12 17381 matrix metalloproteinase 
12
2.172 0.0232 7.993 0.00031
Mmp13 17386 matrix metalloproteinase 
13
6.428 0.02 13.62 0.00657
Mmp14 17387 matrix metalloproteinase 
14
2.345 0.00432 3.99 0.000764
Cell lineagePage 6 of 20
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smooth muscle cell proteins (Cald1, Dstn), in aortas pro-
tected from aneurysm, highlight the importance of vascu-
lar smooth muscle cells in maintaining vascular integrity.
We observed downregulation of the genes encoding
kininogen (kng1), Apolipoprotein CI (Apoc1) and the
neutrophil-associated leucine-rich alpha-2-glycoprotein 1
(Lrg1) amongst others, in aortas of mice resistant to aneu-
rysm suggesting that they may be pathological genes. The
role of these in aneurysm formation warrants further
investigation.
We also investigated genes that might underlie the predi-
lection for suprarenal aneurysm formation within this
model, highlighting downregulation of a number of genes
which may explain the susceptibility of the suprarenal
aorta to aneurysm formation. Urocortin has been shown
in vitro and within animal models to inhibit the effects of
the renin-angiotensin system, thus downregulation of
Ucn3 (urocortin 3) within the suprarenal aorta of ApoE-/
- mice may be relevant to its predilection for aneurysm
formation following angiotensin II infusion [11,12]. We
also demonstrated downregulation of Lama3 (laminin
alpha 3) within the suprarenal aorta. This extracellular
matrix protein has been demonstrated to be present in
reduced concentrations within some human AAAs and
therefore may also be relevant to the preponderance of the
suprarenal aorta to aneurysm formation [27,28]. In vitro
laminin also plays important roles in modulating inflam-
mation and MMP production suggesting its relevance to
aneurysm formation [29,30]. Further studies will be
Cd14† 12475 CD14 antigen 2.068 0.00045 2.549 4.29E-05
Cd68† 12514 CD68 antigen 2.907 0.00865 5.776 0.00162
Csf3r 12986 colony stimulating factor 3 
receptor (granulocyte); 
CD114.
2.627 9.99E-05 2.53 0.00056
FceR1g† 14127 Fc receptor, IgE, high 
affinity I, gamma 
polypeptide; CD23
2.835 0.0275 3.691 0.0125
Anpep 16790 alanyl (membrane) 
aminopeptidase; CD13
2.216 0.000594 3.312 5.46E-05
Cytokines and 
receptors
Il6† 16193 interleukin 6 2.61 0.0411 3.92 0.0136
Il1b† 16176 interleukin 1 beta 3.966 0.0158 5.89 0.00501
Antigen processing 
and presentation
Cd74 16149 Ia-associated invariant 
chain
2.376 0.00037 2.488 7.03E-05
H2-Ab1† 14961 histocompatibility 2, class 
II antigen A, beta 1
2.799 0.000852 3.108 5.10E-06
Shown are genes which were significantly up-regulated (2-fold, uncorrected p value < 0.05 calculated with unpaired t-test) within the aortas of mice 
with AAAs by comparison to both mice that received angiotensin II and did not develop AAAs and also saline control mice. Genes were selected 
from the full list of differentially expressed genes (shown in Additional Files 3 and 4) based on their upregulation in both comparisons, likely 
functional importance and previous association with human AAA. Transcripts associated with no recognised gene are not included. Genes 
highlighted with † have previously been identified as associated with human AAA in a whole genome expression study or other human AAA studies 
[9,10]. Genes highlighted in bold were selected for validation by real time PCR (see Table 6). Cf: compared to; ns: not significant
Table 4: Examples of genes upregulated in the aortas of mice with aneurysms. (Continued)Page 7 of 20
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employing deficient mice.
A small number of previous studies have used expression
arrays to examine gene transcripts associated with AAA in
Table 5: Examples of genes upregulated in the aortas of mice exposed to angiotensin II which did not develop aneurysms. These genes 
are potentially protective against AAA.
Gene symbol Gene ID Description Fold increase cf AAA P value Fold increase cf saline P value
Cald1† 109624 caldesmon 1 2.053388 0.000625 2.379 5.64E-06
Acta2† 11475 actin, alpha 2, smooth muscle, aorta 2.178649 0.0284 2.536 1.84E-06
Sost† 74499 sclerostin 2.659574 0.0118 2.167 9.01E-06
Kcnmb1† 16533 potassium large conductance calcium-
activated channel, subfamily M, beta 
member 1.
2.004008 0.0129 2.262 7.45E-07
Dstn† 56431 destrin 2.169197 0.00498 2.242 6.70E-06
Timp4† 110595 tissue inhibitor of metalloproteinase 4 2 1.99E-05 ns ns
Pdlim3† 53318 PDZ and LIM domain 3 2.12766 0.00386 ns ns
Rgs17† 56533 regulator of G-protein signaling 17 2.439024 0.00106 ns ns
Hspa1l 15482 heat shock protein 1-like 2.020202 0.00844 ns ns
Gabra3 14396 gamma-aminobutyric acid (GABA-A) 
receptor, subunit alpha 3
2.028398 0.00482 ns ns
Btc† 12223 betacellulin, epidermal growth factor 
family member
2.314815 0.0412 ns ns
Fbxo30 71865 F-box protein 30 2.325581 0.000911 ns ns
Hspa1†a 193740 heat shock protein 1A 2.262443 0.00944 ns ns
Mtap1b† 17755 microtubule-associated protein 1B 2.252252 0.0363 ns ns
Xirp1 22437 cardiomyopathy associated 1 2.155172 0.0165 ns ns
Klk10 69540 Kallikrein 10 2.136752 7.42E-05 ns ns
Slc22a1† 20517 solute carrier family 22 (organic cation 
transporter), member 1
2.873563 0.000794 ns ns
Shown are examples of genes which were significantly up-regulated (2-fold, uncorrected p value < 0.05 calculated with unpaired t-test) within the 
aortas of mice that received angiotensin II and did not develop AAAs by comparison to mice which developed AAAs. Also shown is comparison 
with findings from the aortas of saline control mice. Genes were selected from the full list of differentially expressed genes (shown in Additional File 
9) based on their likely functional importance and previous association with human AAA. Genes highlighted with † have previously been identified 
as down-regulated within human AAA in a whole genome expression study [9]. Cf: compared to; ns: not significant.Page 8 of 20
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There are a number of issues to consider when interpret-
ing the results of the present study and those previously
conducted, such as sample sizes, controls used, model
employed (in the case of animal studies) and adjustment
for multiple testing. Only one of the previous studies was
a whole genome expression assessment, similar to the cur-
rent study, with other studies examining much smaller
numbers of transcripts. The sample sizes employed in all
studies means that the power to detect differentially
expressed genes is limited; therefore all current studies
would have been expected to generate a large number of
false negatives. We have therefore concentrated on identi-
fying genes which were identified in the current study and
also in these previous investigations and highlighted these
throughout our tables (a summary of our findings in
comparison with previous studies is provided in table 8).
A number of chemokines were identified in all studies
underlining the findings of the current investigation.
Other common mechanisms identified to be associated
with AAA included pro-inflammatory cytokines and
matrix proteolysis. The design of the current experiment
has some advantages over previous studies in the use of
controls employed. We utilised two control sample types
within study 2, i.e. aortas from mice receiving saline infu-
sion but importantly also from mice that received angi-
otensin II and did not develop aneurysms. This has
enabled us to try and isolate effects associated with AAA
rather than just those due to angiotensin II. Findings in
previous rodent studies may have related in part simply
due to the effects of elastase [32,33]. Controls for human
expression array studies are problematic for a number of
reasons, including the large amount of patient to patient
variations, and the effects of factors that are impossible to
control for in small samples such as differences in medi-
cation taken and co-morbidities [9,28,34].
This study is the first to carry out a whole genome expres-
sion analysis within the angiotensin II- Apo E-/- model. We
used an explorative approach using relatively small num-
bers of arrays (28 in total were included in the array stud-
ies). We were not adequately powered to adjust for
multiple testing given the number of transcripts exam-
ined. Unlike some other microarray studies we have used
real time PCR, IHC and ELISA to confirm some of our
findings rather than relying on RNA assessment alone [9].
Heatmap of 531 genes differentially expressed in the aortas of angiotensin II treated mice that developed aneurysms (n = 5) versus those that did not develop aneurysms (n = 7)Figure 1
Heatmap of 531 genes differentially expressed in the aortas of angiotensin II treated mice that developed 
aneurysms (n = 5) versus those that did not develop aneurysms (n = 7). A complete list of the genes used for this 
analysis is provided in Additional File 3. Expression in the saline controls (n = 6) for each of these genes is also shown. Each line 
in the heatmap represents a gene with mean upregulated (red) or downregulated (green) expression for the three groups. Black 
colour denotes no change in expression. Different patterns of gene expression are indicated as Patterns 1–4 and associated 
gene lists are provided in Additional Files 6, 7, 8 and 9 and Table 4. A Volcano plot (two fold change, p < 0.05) comparing the 
aneurysm group with aneurysm resistant group was used to select genes for this analysis.
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BMC Genomics 2009, 10:298 http://www.biomedcentral.com/1471-2164/10/298Numerous studies have now demonstrated the validity of
microarray platforms therefore we felt it would be useful
to demonstrate the functional relevance of altered RNA
expression [9,35]. Our findings suggest the value of this
mouse model as one to investigate the role of inflamma-
tion, cell recruitment and proteolysis in AAA.
Conclusion
In conclusion our study supports the value of the angi-
otensin II infused ApoE-/- mouse model for investigating
mechanisms and interventions relevant to human AAA.
Methods
Study design
Infusion of angiotensin II induces aortic dilatation partic-
ularly affecting the suprarenal aorta in ApoE-/- mice
[5,6,18-21]. Based on studies carried out in our and other
laboratories the response to angiotensin II is variable,
with some mice developing large aneurysms but other
animals appearing resistant to aneurysm formation with
aortic diameters similar to that of saline controls (Addi-
tional file 12). The infrarenal aorta is protected from
aneurysm formation in these mice. To assess the likely sig-
nalling pathways relevant to aneurysm development and
progression within this mouse model we carried out three
studies (Table 1): 1) We compared RNA expression within
segments of supra and infrarenal aortas from 13 week old
male ApoE-/- mice unexposed to angiotensin II (n = 10). 2)
We compared RNA expression from whole aortas of 17
week old male ApoE-/- mice which had been exposed to
angiotensin II (1.44 g/kg/min) for 4 weeks where there
was clear evidence of aortic aneurysm formation (n = 5)
with that of mice failing to develop aneurysms (n = 7) and
those exposed to saline infusion (n = 6). 3) We selected 2
genes and 5 cellular pathways identified as upregulated
within the aortas of mice with aneurysms for validation
using protein assessments including ELISAs and immuno-
histochemistry (IHC). The selection of genes was based
on their association with pathways we had identified from
pathway analysis of the data and recognised ability to be
able to assess them using ELISAs or IHC. For study 3,
twenty-eight additional 17 week old male ApoE-/- mice
were infused with angiotensin II for 4 weeks. Ten mice in
study 3 died prematurely due to aortic rupture and were
excluded from further analysis in order to avoid post-mor-
tem or post rupture effects confounding assessments, leav-
ing 18 animals in this group.
Mice
This investigation conformed to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85-23,
revised 1996). Ethical approval was obtained from the
local institutional committee prior to commencement of
the study. Male ApoE-/- mice were obtained from Animal
Resources Centre, Canning Vale, Western Australia aged
6–8 weeks. Mice were fed standard chow, and at 13 weeks
either their aortas were harvested (study 1, n = 10) or angi-
otensin II (n = 12 study 2; n = 28 study 3) or saline (n = 6
study 2) infusion commenced. Aortic harvesting and
osmotic minipump placement (Model 2004, ALZET,
Durect Corporation, Cupertino, California, USA) was car-
ried out under ketamine (150 mg/kg i.p.) and xylazine
(10 mg/kg i.p.) anaesthesia as previously described [22].
Table 6: Validation of genes up-regulated in AAA by real time PCR.
Gene symbol Gene ID Description; 
synonym
Relative 
expression in 
AAA
Relative 
expression in 
no AAA
Relative 
expression in 
saline control
P value AAA v 
no AAA
P value AAA v 
saline control
Ccl4† 20303 chemokine (C-C 
motif) ligand 4; 
MIP-1B
52.71 (19.80–
133.40)
5.55 (4.87–9.91) 1.40 (0.84–2.49) 0.009 0.004
Ccl8† 20307 chemokine (C-C 
motif) ligand 8; 
MCP-2
8.84 (5.94–
12.25)
1.66 (1.27–2.73) 0.84 (0.55–1.18) 0.009 0.004
Mmp2† 17390 matrix 
metalloproteinase 
2
4.58 (3.80–
11.00)
2.30 (1.50–3.17) 0.97 (0.81–1.06) 0.004 0.004
Il6† 16193 interleukin 6 70.87 (14.40–
184.59)
9.49 (2.54–16.83) 0.46 (0.17–1.26) 0.030 0.004
Shown are median (inter-quartile range) of relative gene expression (compared to house-keeping gene) in whole aortas used in the micro-array 
studies removed from mice exposed to angiotensin II that developed AAAs (n = 5) or no AAA (n = 7) or saline controls (n = 6).Page 10 of 20
(page number not for citation purposes)
BMC Genomics 2009, 10:298 http://www.biomedcentral.com/1471-2164/10/298The 28 day infusion period and dose of angiotensin II
were selected as these have been routinely used in other
studies within this model [5,6,18-21]. In studies 1 and 2,
mice were euthanized by carbon dioxide asphyxiation, the
aortas perfused with RNAlater® (Qiagen, Doncaster, Victo-
ria, Australia), and harvested from arch to iliac bifurcation
and stored at -80°C for later analysis. For study 3 mice
were euthanized, aortas were perfused with PBS and the
suprarenal aortic segments divided into 2 and stored sep-
arately at -20°C for later IHC and cytokine assessment.
Verification of microarray data for two genes in which aortic expression was related to aneurysm formationFigure 2
Verification of microarray data for two genes in which aortic expression was related to aneurysm formation. 
A) ELISA for aortic osteoprotegerin and transforming growth factor beta-1 (right panel) confirmed microarray expression data 
(left panel). Gene expression data are presented as boxplots of normalised intensity for Tnfsf11b (OPG) and Tgfb1 (TGFb-1) 
for each group (aneurysmal mice n = 5, non-aneurysmal mice n = 7, saline controls n = 6). ELISA data from suprarenal AAAs (n 
= 9) and suprarenal aortas without AAA (n = 9) of ApoE-/- mice infused with angiotensin II. B) Immunohistochemistry confirms 
OPG localisation to aortic media (inset) and thrombus in suprarenal aortas with aneurysm. Aneurysm resistant and saline con-
trol aortas showed minimal OPG staining. Scale bars represent 500 m, except inset where bar represents 50 m.
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BMC Genomics 2009, 10:298 http://www.biomedcentral.com/1471-2164/10/298Table 7: Top 10 KEGG pathways enriched in mouse aortic aneurysms.
Pathway (KEGG linked) Total genes in pathway Number genes upregulated 
in pathway in AAA v no 
AAA
Representative Genes (Entrez 
Gene ID)
P value*
Cytokine-cytokine receptor 
interaction
249 28 Cxcl5 (20311), Cxcl9 (17329), Cxcl10 
(15945), Cxcl12 (20315), Cxcl13 
(55985), Cxcl16 (66102), Cxcl14 
(57266), Xcl1(16963), Cx3cr1 
(13051), Cxcr4 (12767), 
Ccl19(24047), Ccl21a (20298), 
Ccl21b (18829), Ccl2 (20296), Ccl12 
(20293), Ccl4 (20303), Ccl7 (20306), 
Ccl5 (20304), Ccl8 (20307), Ccr5 
(12774), Il6 (16193), Csf3r (12986), 
Csf2rb2 (12984), Il7r (16197), Il2rg 
(16186), Il10ra (16154), Tnfrsf13b 
(57916), Il1b (16176)
8.70e-26
Leukocyte transendothelial 
migration
115 15 Cldn11 (18417), Mmp2 (17390), 
Mmp9 (17395), Ptpn11, Cybb 
(13058), Ncf2 (17970), Ncf4 (17972), 
Thy1 (21838), Cxcl12 (20315), Cxcr4 
(12767), Rac2 (19354), Vav1 (22324), 
Ptk2b(19229), Cxcl13 (55985), 
Cxcl14 (57266)
4.20e-15
Focal adhesion 194 11 Col3a1 (12825), Col1a1 (12842), 
Comp (12845), Reln (19699), Thbs1 
(21825), Thbs2 (21826), Igf1 (16000), 
Igf1r (16000), Vav1 (22324), Rac2 
(19354), Itga11(319480), Itga6 
(16403)
1.22e-7
B cell receptor signaling 
pathway
69 10 Cd72(12517), Cd79b (15985), Fcgr2b 
(14130), Inpp5d(16331), Btk (12229), 
Blnk (17060), Vav1(22324), 
Rac2(19354), Rasgrp3(240168), 
Ifitm1(68713)
3.75e-11
Natural killer cell mediated 
cytotoxicity
129 10 Hcst (23900), Klrd1 (16643), 
Fcgr3(14131), Fcer1g (14127), 
Tyrobp (22177, Ptk2b (19229), Vav1 
(22324), Lcp2(16822), Cd48 (12506), 
Rac2 (19354)
8.70e-9
Hematopoietic cell lineage 86 10 H2-Eb1(14969), Il7r (16197), Cd3d 
(12500), Fcgr1(14129), Anpep 
(16790), Il6 (16193), Il1b(16176), 
Csf3r (12986), Itga6(16403), 
Cd14(12475)
3.24e-10
Jak-STAT signaling pathway 155 8 Il6(16193), Csfrb2(12984), 
Csf3r(12986), Il10ra(16154), 
Il2rg(16186), Il7r(16197), Jak3 
(16453), Socs3(12702)
1.18e-6
ECM-receptor interaction 81 8 Reln(19699), Itga11(319480), 
Itga6(16403), Col3a1(12825), 
Col1a1(12842), Thbs1(21825), 
Thbs2(21826), Sdc3(20970)
1.43e-7Page 12 of 20
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Aortas were placed on a black background and digitally
photographed (Coolpix 4500, Nikon). Maximum diame-
ters of the aortic arch, thoracic, suprarenal and infrarenal
aorta were determined from the images using computer-
aided analysis (Scion Image, Scion Corporation). Prelim-
inary studies (n = 27) established that these measure-
ments could be repeated with good intra-observer
reproducibility (Coefficient of repeatability 0.98, 95%
confidence intervals 0.975–0.982, and coefficient of vari-
ation 4%).
Microarrays
Total RNA was extracted from homogenised aortas using
the TRI reagent (Sigma) and RNeasy Mini kits (Qiagen)
and analysed on the HP 2100 Bioanalyzer (Agilent Tech-
nologies) for integrity using Eukaryotic total RNA nano
chips (Agilent) (Additional File 11). All samples had RNA
integrity scores between 6.9 and 8.1. For study 1, RNA
extracted from the pooled suprarenal aortas of two mice
was compared with that obtained from the infrarenal aor-
tic segments of the same mice. A total of 10 mice (i.e. 5
pairs of pooled segments) were included in study 1. For
study 2, RNA extracted from the whole aortas of mice with
aneurysms (n = 5, Additional File 12A) was compared
with that extracted from the whole of aortas of saline con-
trols (n = 6, Additional File 12C) and mice exposed to
angiotensin II which did not develop aneurysms (n = 7,
Additional File 12B). No sample pooling was carried out
in study 2. RNA hybridization was performed, and gene
expression profiles determined, using CodeLink Mouse
Whole Genome Bioarray chips (GE healthcare, Amer-
sham, Bioscience) (study 1, n = 10) and Illumina Mouse
Sentrix 6 version 1.1 Beadchips (study 2, n = 18). For
study 1 total RNA from infrarenal and suprarenal aortas
was supplied to GenUS BioSystems Inc. (Northbrook, Illi-
nois USA) who conducted cDNA synthesis, hybridization
and scanning using standard protocols. In brief, 10 g of
total RNA was used for each 'sample versus sample' com-
parison and first and second strand cDNA were prepared
using the Codelink™ iExpress Expression assay Reagent kit
(GE healthcare Amersham). Biotinylated cRNA target was
prepared from the cDNA template by linear amplification
using biotin-dNTPs and verified on a Bioanalyzer 2100.
The cRNA was fragmented to uniform size and once again
verified on the Bioanalyzer 2100. Each fragmented,
biotin-labeled cRNA was added to a Codelink Mouse
Whole Genome array which contained 34,957 probes tar-
geting unique mouse transcripts. The bioarrays were
washed, exposed to Cy5 streptavidin and scanned using
GenePix 4000B laser scanner. Scanned image files were
examined using CodeLink image and data analysis soft-
ware (GE healthcare, Amersham, Bioscience). The image
information was converted into spot intensity values
using CodeLink™ Expression Analysis software (GE
healthcare). The generated values were exported to Gene-
Spring GX 7.3.1 software (Silicon Genetic, USA) for fur-
ther analysis. Study 2 labelling, hybridisation and
scanning was done at the SRC Microarray Facility, Univer-
sity of Queensland, Brisbane, Australia according to the
manufacturer's instructions. For study 2 total RNA was
amplified in a single-round of in vitro transcription ampli-
fication that allowed incorporation of biotin-labeled
nucleotides using the Illumina TotalPrep RNA amplifica-
tion kit (Ambion, Inc., Austin, TX). mRNA samples were
assessed for integrity and purity prior to hybridization
using the Bioanalyser 2100 with mRNA Nano chips (Agi-
lent Technologies). cRNA of each sample was hybridized
to an Illumina Mouse WG-6 V1.1 BeadChip followed by
washing, blocking, and streptavidin-Cy3 staining steps,
and scanning with a high-resolution Illumina BeadArray
reader scanner. The data extraction was performed by
using Illumina Bead Studio V2.3.41 software with the out-
put being raw, non-normalized bead summary values.
The BeadStudio matrix contains the summarised expres-
sion values (Avg_Signal), standard error of the bead repli-
cates (BEADSTDEV), number of beads used
(Avg_NBEADS) and a detection score, which estimates the
confidence limit of detection of a gene. The performance
of the built-in controls that accompany each Illumina
beadchip experiment was assessed as part of the Bead Stu-
dio V2 experiment performance report and was found to
Toll-like receptor signaling 
pathway
101 7 Cd14(12475), Il6 (16193), 
Il1b(16176), Ccl5(20304), 
Ccl4(20303), Cxcl10(15945), 
Cxcl9(17329),
3.52e-6
Cell adhesion molecules 
(CAMs)
158 7 H2-Ab1(14961), H2-Eb1(14969), H2-
DMb1(14999), Selpl (20345), 
Sdc3(20970), Itga6(16403), 
Cldn11(18417)
4.42e-5
Pathways were identified using WebGestalt by comparison of differentially expressed genes in the aortas of mice that did and did not develop 
aneurysms following angiotensin II infusion. Transcripts with >2 fold increase in expression in AAA compared to no AAA and p < 0.05 were 
submitted for pathway analysis. Pathways are linked to the KEGG website http://www.genome.jp and genes are linked to gene information. P value 
indicates the uncorrected significance of enrichment calculated from the hypergeometric test.
Table 7: Top 10 KEGG pathways enriched in mouse aortic aneurysms. (Continued)Page 13 of 20
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BMC Genomics 2009, 10:298 http://www.biomedcentral.com/1471-2164/10/298Immunohistochemistry demonstrating inflammatory cells in the suprarenal aorta of mice with aneurysms demonstrating func-tional c nfirmation of microarray expression d taFigure 3
Immunohistochemistry demonstrating inflammatory cells in the suprarenal aorta of mice with aneurysms 
demonstrating functional confirmation of microarray expression data. Boxplots show normalised expression of 
genes that are markers of various haematopoietic cell lineages; Csf3r (neutrophils), Cd3d (T lymphocytes), Blnk (B lym-
phocytes), Itgax (dendritic cells) and Cd68 (monocyte/macrophages) from aneurysmal (n = 5), non-aneurysmal (n = 7) and 
saline control (n = 6) mice. Shown are sections stained for (A) neutrophils, (B) T lymphocytes (C) B lymphocytes (D) dendritic 
cells (E), macrophages in mice with aneurysms (i) and those without aortic dilatation (ii). Scale bars represent 100 m.
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for intactness of the biological specimens, negative con-
trols to establish gene expression detection limits and
hybridization controls including low and high stringency
controls and biotin signal generation controls. The raw
data matrix extracted from Beadstudio was uploaded into
GeneSpring GX 7.3.1 (Silicon Genetics, Redwood City,
CA) software for downstream analysis. Details of Gene-
Spring analysis including data transformations, per chip
and per gene normalisations are described below in Anal-
ysis and Design.
Real time PCR
Using RNA obtained for the mice employed in the micro-
array investigations in study 2 we validated findings for 4
genes (Ccl4, Ccl8, Il6 and Mmp2) using real time PCR.
RNA samples from mice exposed to angiotensin II that
developed aneurysms (n = 5), mice exposed to angi-
otensin II that did not develop aneurysms (n = 7) and
Table 8: Comparison of results from this study and those from other expression arrays for AAA.
Ref. Transcripts 
examined
Species Number of samples/
controls
Tissue of interest Control tissue Similar genes 
upregulated
9 18057 oligonucleotides 
microarray
Human 6/7 AAA Normal# Chemokines (e.g. CCL2, 
CCL4, CCL8, CCR5, 
CXCL5, CXCR4, 
TNFRSF13B)
Pro-inflammatory 
cytokines (e.g. IL1B, 
IL2RG)
Matrix metalloproteinase 
(e.g. MMP9)
Cell lineage markers (e.g. 
CD53, CD68, CD72)
32‡ 1181 cDNA clones Mice 3/3** Elastase induced AAA Inactivated elastase 
infused aortas
Pro-inflammatory 
cytokines (e.g. IL1B, IL6, 
INF, IGF1)
Chemokines (e.g. CCL7)
JAK-STAT signalling (e.g. 
SOC3)
31‡ 375 cDNA clones Human 1/1* AAA body AAA neck Chemokines (e.g. 
CXCR2)
28‡ 265 cDNA clones Human 7/5/5† AAA AOD and normal† Matrix metalloproteinase 
(e.g. MMP9, MMP12)
Pro-inflammatory 
cytokines (e.g. IL1B, IL6)
Chemokines (e.g. CCL4, 
CCR5)
Fibrinolysis (e.g. uPA)
33‡ 8799 cDNA clones 
microarray
Rat 1/1‡‡ Elastase induced AAA Saline infused aortas Oxidative stress (Heme 
oxygenase, lipoxygenase)
34‡ 1176 cDNA clones Human 4/4 AAA normal†† Cathepsins (e.g. cathepsin 
H)
Matrix metalloproteinase 
(e.g. MMP9)
Chemokines (e.g. 
CXCR4, CCL5)
*Results provided limited; †5 controls from aortic occlusive disease (AOD) from patients undergoing bypass and 5 controls from organ donors 
which were not age-matched; ‡These studies did not adjust for multiple testing; **pooling of samples was performed with 3 pools of interest 
compared with 3 controls for 4 different time periods after elastase infusion; ††Controls were from organ donor who were not matched; 
‡‡Appears to have been comparison of one pool of samples from elastase induced aaas and one pool from controls examined on two microarrays 
each; #controls from post-mortem samples. Ref. = reference.Page 15 of 20
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The QuantiTect SYBR Green one-step RT-PCR Kit (Qia-
gen) and Quantitect Primer Assays (Qiagen) (Il6,
QT00098875; Ccl4, QT00154616; Ccl8, QT00128548;
Mmp2, QT00116116) were used according to the manu-
facturer's instructions with 25 ng of total RNA as template.
Primers for mouse Gapdh were used to amplify the house-
keeping gene (Qiagen, QT01658692). Standard curves for
each gene including the housekeeping gene were con-
structed using duplicate sets of five (5) 10-fold serial dilu-
tions of equal volumes of the pooled saline control RNAs.
Negative and "minus-RT" controls were also included. All
reactions were independently repeated in duplicate to
ensure the reproducibility of the results. Cycling
parameters were as follows: 50°C 30 min for RT; 95°C 15
min; 40 cycles of 94°C 15 sec, 55°C 30 sec, 72°C 30 sec.
Data were viewed and analysed using the Rotor-Gene's
real-time analysis software (Rotor-Gene 6000; Corbett
Life Science, Sydney). The relative expression of the gene
of interest in each sample was calculated by the Rotor-
Gene software using the concentration-Ct-standard curve
method and normalised using the average expression of
Gapdh for each sample. SSPS statistical software was used
to calculate median and interquartile ranges for expres-
sion of each gene of interest in each group.
IHC
Serial cryostat sections 7 m thick were cut from suprare-
nal aortas with and without aneurysms prior to staining
for inflammatory cells. Serial frozen sections were air-
dried, fixed in acetone for 10 min at -20°C, air dried and
rehydrated with PBS before being incubated in 3% H2O2/
0.1% sodium azide/PBS to block endogenous peroxidase.
For macrophage detection, sections were blocked in 2%
normal goat serum in PBS followed by staining using pan-
macrophage antibody (clone MOMA-2, Abcam
AB33451), and goat anti-rat HRP (Millipore AP136P). Rat
IgG (Sigma I4131) was used as isotype control. Detection
of osteoprotegerin (OPG) was carried out using bioti-
nylated goat anti-mouse OPG (R&D BAF459) diluted to 1
g/ml in blocking buffer followed by Vectastain Elite
ABC-HRP (Vector Laboratories). Biotinylated goat-IgG
was used as isotype control (Vector Laboratories
VEBI1001). T cells (CD3e FITC clone 145-2C11, BD Bio-
sciences 553061), B cells (CD45R/B220 biotin clone RA3-
6B2, BD Biosciences 550385), dendritic cells (CD11c
biotin clone HL3, BD Biosciences 553800) and neu-
trophils (Ly6G/Ly6C(Gr-1) FITC clone RB6-8C5, BD Bio-
sciences 553127) were demonstrated using either anti-
FITC HRP (Invitrogen), biotinyl-tyramide (Perkin Elmer),
SA-HRP (Perkin Elmer) for FITC-conjugated antibodies or
SA-HRP, biotinyl-tyramide, SA-HRP for biotinylated anti-
bodies. Appropriate isotype controls were added to other
sections (all BD Biosciences). Slides were incubated in the
peroxidase substrate 3, 3'-diamminobenzidine
(ImmPACT DAB, Vector), counterstained in Mayer's Hae-
matoxylin, dehydrated, cleared in xylene and mounted in
Depex mounting medium. Sections were photographed
using a Nikon Eclipse 50i microscope, Digital Sight cam-
era and NIS-elements software.
Cytokine studies
Protein was extracted from individual frozen suprarenal
aortic segments by homogenising in buffer (10 mM
cacodylic acid, 60 mM L-arginine, 0.25% triton x-100 in
PBS, pH 7.2) and centrifuging at 18,000 × g at 4°C for 20
min. Supernatant protein was quantified by the Bradford
technique (Protein Assay, Bio-Rad, Hercules, California,
USA). Concentrations of OPG and transforming growth
factor beta-1 (TGFb-1) were assessed using commercial
ELISAs (Quantikine, R&D Systems, MOP00 for OPG,
MB100B for TGFb-1) and expressed as pg/mg of protein.
Initial tests were performed to determine an appropriate
amount of extracted aortic protein to load in each well to
suit the ELISA standard curves (10 g for OPG ELISA, 20
g for TGFb-1 ELISA). Serum and extracted aortic proteins
from OPG deficient mice were confirmed as having zero
readings using the OPG ELISA (data not shown). Batch
analysis of the samples was carried out to facilitate com-
parison between groups. We have previously reported
excellent reproducibility of similar assays [36].
Analysis and design
We designed the current study as an exploratory analysis
expecting a minimal level of false discovery inevitable in
analysis of large microarray gene probes. Sample size cal-
culations were conducted using SPCalc [37,38]. For study
1 (which included paired samples) we aimed to detect a
1.5-fold difference at a power of 0.8 (alpha uncorrected
0.05), while for study 2 (which included unpaired sam-
ples) we aimed to detect a 2-fold difference. Based on the
number of gene probes to be examined (26,522) we
wished to control the false positives to a mean of 2
[17,18]. We estimated the total number of arrays needed
for study 1 and 2 were 10 and 18 respectively. Microarray
data were imported into Genespring GX 7.3.1 (Agilent)
for analysis. The data from the individual bioarrays have
been deposited in NCBIs Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo/) and are acces-
sible through GEO accession number GSE7006 (GEO
Accession viewer) for study 1 and GSE12591
http:www.ncbi.nlm.nih.gov/gequeracc.cgi?token=rduxb
siqmqswefi&acc=GSE12591 for study 2. For study 1
which used paired samples, normalisations were as fol-
lows: each chip was normalised to the median intensity of
the array; each gene was normalised relative to the supra-
renal sample of each pair. Thus the expression of each SRA
sample was normalised to 1. Volcano plots were used to
identify differentially expressed genes with >1.5 fold dif-
ference in expression and p < 0.05. Statistical analysis wasPage 16 of 20
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paring the mean infrarenal/suprarenal ratio to a baseline
value of 1 for each sample pair. In study 2 we followed the
standard normalization procedures recommended for the
GeneSpring GX 7.3.1 software for one-colour array data.
In brief, data transformation was corrected for a low sig-
nal, with values recorded at <0.01 increased to the mini-
mum (0.01). Default settings were used for experiment
normalisation which included chip normalisation to 50th
percentile and gene normalisation to the median. The
cross gene error model was used to further filter low qual-
ity data. We sought to identify genes with a 2-fold differ-
ential expression within the aortas of mice with and
without aneurysms based on an uncorrected p value of <
0.05 included in our sample size estimate. We initially
compared findings from mice that received angiotensin II
and developed AAAs (n = 5) with both other groups of
mice (n = 7 and 6). Genes showing a greater than 2 fold
difference in expression between groups (unpaired t-test
(unequal variance) p < 0.05), were considered to be differ-
entially expressed. We reasoned that the most significant
findings would relate to genes differentially expressed
between angiotensin II perfused mice, that did (n = 5) and
did not (n = 7) develop aneurysms. Volcano plots were
used to identify differentially expressed genes between the
aortas of these two groups of mice. This group of 531
genes was further investigated by hierarchical clustering in
GeneSpring, in which a tree of transcripts or genes is built
by successively finding the two most similar gene expres-
sion patterns from the full transcript set. Individual sam-
ples were then arranged in a condition tree according to
overall similarity. We also included the saline group in
this clustering analysis in order to show how these 531
genes are expressed in control aortas. Genes with similar
expression patterns were grouped as hierarchical clusters
with distances between samples computed using Pearson
correlations for similarity measures and average linkage as
the clustering algorithm. Hierachical clustering revealed
several major nodes in the gene tree structure which indi-
cated at least 4 different patterns of gene expression. Lists
of differentially expressed genes were examined for bio-
logically relevant associations using Gene Ontologies and
Kyoto Encyclopedia of Genes and Genome (KEGG) path-
way analysis in the web-based software Webgestalt http://
bioinfo.vanderbilt.edu/webgestalt. Quantitative real time
PCR outcomes in study 2 and concentrations of cytokines
measured in study 3 were compared between groups
using Mann Whitney U test.
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Additional file 1
List of transcripts differentially expressed in supra and infrarenal aor-
tas. Transcripts included were expressed at 1.5 fold different levels and 
significant at uncorrected p < 0.05. Included are genebank and unigene 
names, uncorrected p values and ratio of transcripts expression compared 
between supra and infrarenal aortas.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S1.xls]
Additional file 2
Number of differentially expressed transcripts comparing aortas of 
mice with and without aneurysms, in addition to saline controls. 
Transcripts included were expressed at 2 fold different levels and signifi-
cant at uncorrected p < 0.05.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S2.pdf]
Additional file 3
List of transcripts differentially expressed in aortas of mice exposed to 
angiotensin II which did (AAA group) and did not (no AAA group) 
develop aneurysms (n = 531). We considered this the most important 
comparison since the controls were in all ways similar to the group of inter-
est except they did not have AAAs. Transcripts included were expressed at 
2 fold different levels and significant at uncorrected p < 0.05. Transcripts 
with higher expression in AAA group are indicated in yellow, whilst those 
with higher expression in no AAA group are coloured blue. Included are 
gene symbol (where an identified gene is associated with the transcript), 
genebank accession number, fold difference, uncorrected p values, gene 
description, and Illumina Probe identification number.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S3.xls]Page 17 of 20
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List of transcripts differentially expressed in aortas of mice exposed to 
angiotensin II which developed aneurysms (AAA) and saline controls 
(n = 1196). Transcripts included were expressed at 2 fold different levels 
and significant at uncorrected p < 0.05. Included are gene symbol (where 
an identified gene is associated with the transcript), genebank accession 
number, fold difference, uncorrected p values, gene description, and Illu-
mina Probe identification number.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S4.xls]
Additional file 5
List of transcripts differentially expressed in aortas of mice exposed to 
angiotensin II which did not develop aneurysms (no AAA) and saline 
controls (n = 654). Transcripts included were expressed at 2 fold different 
levels and significant at uncorrected p < 0.05. Included are gene symbol 
(where an identified gene is associated with the transcript), genebank 
accession number, fold difference, uncorrected p values, gene description, 
and Illumina Probe identification number.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S5.xls]
Additional file 6
List of pattern 1 transcripts (n = 104) which were downregulated with 
the aortas of aneurysm resistant mice (see results and Figure 1). 
Included are gene symbol (where an identified gene is associated with the 
transcript), genebank accession number, uncorrected p values, gene 
description, Illumina Probe identification number and fold difference 
comparing aortas of mice exposed to angiotensin II that did (AAA) and 
did not develop aneurysms (no AAA).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S6.xls]
Additional file 7
List of pattern 2 transcripts which were upregulated in aortic aneu-
rysms (n = 325; see text and figure 1). Included are gene symbol (where 
an identified gene is associated with the transcript), genebank accession 
number, uncorrected p values, gene description, Illumina Probe identifi-
cation number and fold difference compared to aortas of mice with no 
aneurysm (no AAA).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S7.xls]
Additional file 8
List of genes which were downregulated in the aortas of mice exposed 
to angiotensin II which did not develop aneurysms (no AAA) by com-
parison to both mice developing aneurysms (AAA) and also saline con-
trols (n = 10). The list of genes was generated from pattern 3 transcripts 
excluding those that were associated with no known gene or which were 
not significantly different (2-fold, p < 0.05) by comparison to saline con-
trols in addition (n = 7). These genes potentially have a pathological role 
in AAA. Genes highlighted with † have previously been identified as 
upregulated within human AAA biopsies in a whole genome expression 
study [9]. Included are gene symbols, gene description, fold difference and 
uncorrected p values comparing aortas with aneurysms and saline control 
aortas to aneurysm-resistant aortas.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S8.pdf]
Additional file 9
List of transcripts which were upregulated in the aortas of mice resist-
ant to aneurysm formation (n = 85). Transcripts highlighted in yellow 
are increased (>2 fold, p < 0.05) in the no AAA group when compared to 
both AAA and saline groups. These genes are potentially protective role 
against AAA. Included are gene symbol (where an identified gene is asso-
ciated with the transcript), genebank accession number, uncorrected p 
values, gene description, Illumina Probe identification number and fold 
differences when comparing aortas resistant to aneurysm formation to aor-
tas with aneurysms and saline control aortas.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S9.xls]
Additional file 10
Webgestalt analysis of transcripts upregulated in aortas of mice with 
aneurysms compared to those without. Both groups of mice received 
angiotensin II. Of 376 recognised transcripts 302 were known genes and 
116 were assigned to one or more KEGG pathways. Included are gene 
symbol (where an identified gene is associated with the transcript), gene 
description, Illumina Probe identification number and KEGG title.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-298-S10.xls]
Additional file 11
Examples of mouse RNA samples examined on the Agilent Bioana-
lyser. The 10 pooled samples (2 supra or infra renal segments each) used 
in study 1 (with repetition of 1 sample) were analysed in comparison to 
molecular weight markers (far left), 18 and 28S RNA controls (far right). 
All samples had RNA integrity scores of between 7.5 and 8.1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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